Related Experiment Video

Updated: Jun 3, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Treatment of diabetic patients with non-ST-elevation myocardial infarction

Emanuele Barbato1

  • 1Cardiovascular Center OLV Hospital, Aalst, Belgium. emanuele.barbato@olvz-aalst.be

Journal of Cardiovascular Medicine (Hagerstown, Md.)
|March 5, 2011
PubMed

Insights

Diabetic patients with myocardial infarction face higher mortality risks due to limited aggressive treatments. New, effective drug therapies and intensified treatment strategies are crucial for improving outcomes in this high-risk population.

Area of Science:

  • Cardiology
  • Diabetology
  • Pharmacology

Background:

  • Patients with diabetes mellitus and non-ST-elevation myocardial infarction (NSTEMI) exhibit elevated mortality rates.
  • Suboptimal treatment strategies and pharmacologic therapy efficacy contribute to the heightened risk in diabetic NSTEMI patients.

Purpose of the Study:

  • To highlight the increased mortality risk in diabetic patients experiencing NSTEMI.
  • To emphasize the necessity for more aggressive treatment approaches and advanced pharmacologic options for this patient group.

Main Methods:

  • Review of current treatment guidelines and pharmacologic advancements for NSTEMI in diabetic patients.
  • Analysis of risk factors and outcomes associated with NSTEMI in the diabetic population.

Main Results:

  • Diabetic patients with NSTEMI are a vulnerable cohort with poorer prognoses.
  • Current treatment paradigms may not adequately address the complexities of NSTEMI in diabetes.

Conclusions:

  • Aggressive treatment strategies are imperative for improving survival in diabetic NSTEMI patients.
  • The integration of novel and effective pharmacologic therapies is essential for optimizing care and reducing mortality.

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...